phorbolol myristate acetate has been researched along with naphthalimides in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Li, Y; Lin, B; Liu, J; Lu, Y; Qian, X; Shao, J; Shen, K; Xu, Y; Yin, P | 1 |
1 other study(ies) available for phorbolol myristate acetate and naphthalimides
| Article | Year |
|---|---|
7b, a novel amonafide analog, inhibited proliferation and phorbol 12-myristate 13-acetate/phytohemagglutinin-induced inflammatory responses of Jurkat T cells via p73-dependent pathway and decrease of nuclear factor-κB DNA-binding, respectively.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cytokines; DNA Damage; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Inflammation Mediators; Jurkat Cells; Mitochondria; Naphthalimides; NF-kappa B; Nuclear Proteins; Oxidation-Reduction; Phytohemagglutinins; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2013 |